Shiree S.
About Shiree S.
Shiree S. serves as the Senior Regional Medical Manager at Supernus Pharmaceuticals, Inc., where she leverages her extensive experience in clinical research and product lifecycle management. With a Ph.D. in Environmental Toxicology and over seven years in preclinical research, she possesses a strong foundation in endocrinology, metabolism, and neurology.
Work at Supernus Pharmaceuticals
Shiree S. serves as the Senior Regional Medical Manager (Sr. MSL) at Supernus Pharmaceuticals, Inc. since 2022. In this role, she manages product lifecycles, which is essential for medical affairs. Her responsibilities include overseeing clinical research initiatives and ensuring compliance with FDA regulations. Shiree's expertise in managing patient-reported outcomes, particularly in neurology, aligns with the company's focus on developing treatments for central nervous system disorders.
Education and Expertise
Shiree S. holds a Ph.D. in Environmental Toxicology with a specialization in Molecular Endocrinology from Southern University and A&M College. She also earned a Bachelor's Degree in Pharmacy from Osmania University. Her educational background provides a strong foundation for her work in medical affairs and clinical research. Shiree has over seven years of experience in preclinical research focused on endocrinology and metabolism, which complements her current role in neurology.
Background
Shiree S. has a diverse professional background in clinical research and medical affairs. Prior to her current position, she worked at IQVIA as a Clinical Research Associate and Clinical Liaison from 2018 to 2020. She also served as a Medical Science Liaison at Aquestive Therapeutics for five months in 2021. Earlier in her career, she spent seven years at UT Southwestern Medical Center, where she held roles as a Research Scientist and Research Study Coordinator, gaining extensive experience in clinical research and team leadership.
Clinical Research Experience
Shiree S. has significant clinical research experience, particularly in phase 2 and 3 trials. This experience has equipped her with a deep understanding of the drug development process, which is critical for her role in medical affairs. Her strong knowledge of FDA regulations and monitoring guidelines supports her work in ensuring compliance and safety in clinical research, particularly in the fields of neurology and oncology.